Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Fosså · SciRah

Researcher profile · Semantic Scholar

A. Fosså

Share profile

A. Fosså — researcher profile on SciRah

h-index: 33
Works: 178
Citations: 5,941

Most-cited papers

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
Fritz Van Rhee, P. Voorhees, A. Dispenzieri, A. Fosså +38 more
2018Blood381 citations Open access
Semantic Scholar
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
Fritz Van Rhee, E. Oksenhendler, G. Srkalović, P. Voorhees +25 more
2020Blood Advances206 citations Open access
Semantic Scholar
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
P. Borchmann, J. Ferdinandus, G. Schneider, A. Moccia +46 more
2024The Lancet119 citations Open access
Semantic Scholar
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised contro
C. Mauz-Körholz, J. Landman-Parker, W. Balwierz, R. Ammann +31 more
2021The Lancet Oncology72 citations Open access
Semantic Scholar
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
F. Hoel, A. Hoel, I. K. Pettersen, Ingrid G. Rekeland +16 more
2021JCI Insight57 citations Open access
Semantic Scholar
Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy
H. Nielsen, B. Nedrebø, A. Fosså, J. R. Andersen +11 more
2022International Journal of Obesity51 citations Open access
Semantic Scholar
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
S. Luminari, A. Fosså, J. Trotman, D. Molin +8 more
2023Journal of Clinical Oncology48 citations Open access
Semantic Scholar
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
S. Pierson, Sushila A. Shenoy, A. Oromendia, A. Gorzewski +21 more
2021Blood Advances43 citations Open access
Semantic Scholar
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
C. Mauz-Körholz, J. Landman-Parker, A. Fernández-Teijeiro, A. Attarbaschi +30 more
2023The Lancet Oncology41 citations Open access
Semantic Scholar
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease
C. Nabel, S. Sameroff, Dustin J. Shilling, Daisy V. Alapat +12 more
2019PLoS ONE40 citations Open access
Semantic Scholar
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study.
J. Biccler, I. Glimelius, S. Eloranta, K. Smeland +10 more
2019Journal of Clinical Oncology37 citations Open access
Semantic Scholar
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
Ingrid G. Rekeland, A. Fosså, A. Lande, I. Ktoridou-Valen +10 more
2020Frontiers in Medicine33 citations Open access
Semantic Scholar
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder
S. Pierson, J. Khor, Jasira Ziglar, Amy Y. Liu +30 more
2020Cell Reports Medicine32 citations Open access
Semantic Scholar
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life
S. Eikeland, K. Smeland, F. Mols, U. Fagerli +3 more
2021Acta oncologica31 citations Open access
Semantic Scholar
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Maurizio Martelli, L. Ceriani, G. Ciccone, U. Ricardi +44 more
2024Journal of Clinical Oncology30 citations Open access
Semantic Scholar
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
S. Pierson, Laura Katz, Reece Williams, Melanie D. Mumau +8 more
2022Nature Communications29 citations Open access
Semantic Scholar
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
D. Fajgenbaum, David Wu, A. Goodman, R. Wong +19 more
2020American journal of hematology/oncology29 citations Open access
Semantic Scholar
No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
I. Lagerlöf, H. Holte, I. Glimelius, M. Björkholm +16 more
2020British Journal of Haematology24 citations Open access
Semantic Scholar
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
S. Pierson, J. Brandstadter, D. Torigian, Adam Bagg +24 more
2025Blood Advances22 citations Open access
Semantic Scholar
Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue
A. Fosså, Knut Halvor Bjøro Smeland, Ø. Fluge, K. Tronstad +4 more
2020PLoS ONE18 citations Open access
Semantic Scholar
Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment
S. Eikeland, K. Smeland, V. C. Simensen, U. Fagerli +3 more
2023Acta oncologica15 citations Open access
Semantic Scholar
Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
Rasmus Rask Kragh Jørgensen, F. Bergström, S. Eloranta, Marianne Tang Severinsen +14 more
2024JCO Clinical Cancer Informatics14 citations Open access
Semantic Scholar
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma
Friedrich Christian Franke, Adrian Damek, Jonas Steglich, L. Kurch +24 more
2023Pediatric Radiology14 citations
Semantic Scholar
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Stefanie H. Müller, A. Lai, M. Valkovskaya, K. Michailidou +203 more
2023Genome Medicine14 citations Open access
Semantic Scholar
IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL
M. Martelli, E. Zucca, B. Botto, I. Kryachok +32 more
2021Hematological Oncology13 citations Open access
Semantic Scholar
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial.
J. Ferdinandus, G. Schneider, A. Moccia, Richard Greil +25 more
2025The Lancet Oncology12 citations Open access
Semantic Scholar
First-in-Human Phase 1 Study of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Non-Hodgkin Lymphoma
F. Schjesvold, T. Jelínek, K. Polgárová, L. Pour +21 more
2024Blood12 citations
Semantic Scholar
Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study
Kjersti Lia, R. R. K. Jørgensen, Bente L.Wold, Ø. Fluge +5 more
2023Haematologica12 citations Open access
Semantic Scholar
Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group
P. Borchmann, A. Moccia, Richard Greil, Mark S. Hertzberg +29 more
2022Blood12 citations Open access
Semantic Scholar
Digital health interventions to treat overweight and obesity in children and adolescents: An umbrella review
T. Flølo, C. Tørris, Kirsti Riiser, Kari Almendingen +12 more
2025Obesity Reviews11 citations
Semantic Scholar
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study
J. Entrop, C. Weibull, K. Smedby, L. Jakobsen +9 more
2023International Journal of Cancer11 citations Open access
Semantic Scholar
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
R. Kluge, T. Wittig, Thomas W. Georgi, L. Kurch +14 more
2020Journal of Nuclear Medicine11 citations Open access
Semantic Scholar
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.
J. Ferdinandus, H. Kaul, A. Fosså, A. Huettmann +31 more
2025Journal of Clinical Oncology10 citations
Semantic Scholar
A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma
Kjersti Lia, R. R. K. Jørgensen, Per Wikman, Bente L. Wold +8 more
2025Haematologica10 citations Open access
Semantic Scholar
PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma: Results of the Phase 2 Part of the GHSG HD21 Trial
J. Ferdinandus, H. Kaul, A. Fosså, A. Huettmann +25 more
2024Blood10 citations
Semantic Scholar
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Ingrid G. Rekeland, Kari Sørland, Lisbeth Lykke Neteland, A. Fosså +6 more
2024PLoS ONE10 citations Open access
Semantic Scholar
Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial
P. Borchmann, A. Moccia, R. Greil, G. Schneider +29 more
2023Blood10 citations Open access
Semantic Scholar
Bleomycin Affects Lung Function for at Least 5 Years after Treatment for Hodgkin Lymphoma - Data from the International, Randomised Phase 3 Rathl Trial
Elizabeth H Phillips, A. Kirkwood, Christina Hague, Jørgen Vestbo +10 more
2023Blood10 citations
Semantic Scholar
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial.
S. Daw, A. Claviez, L. Kurch, D. Stoevesandt +24 more
2025JAMA Oncology9 citations Open access
Semantic Scholar
Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.
P. Borchmann, A. Moccia, Richard Greil, G. Schneider +16 more
2024Journal of Clinical Oncology8 citations
Semantic Scholar
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas
A. Fischer, T. Albert, N. Moreno, M. Interlandi +51 more
2024Nature Communications8 citations Open access
Semantic Scholar
Two truncating variants in FANCC and breast cancer risk
T. Dörk, P. Peterlongo, A. Mannermaa, M. Bolla +199 more
2019Scientific Reports8 citations Open access
Semantic Scholar
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.
E. Zucca, A. Davies, I. Kryachok, G. Ciccone +16 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar
Reproduction patterns among non‐Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population‐based matched cohort study
J. Entrop, C. Weibull, K. Smedby, L. Jakobsen +9 more
2023British Journal of Haematology7 citations Open access
Semantic Scholar
T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
Ninja Övergaard, Kjersti Lia, P. Asdahl, Per Wikman +10 more
2022HemaSphere7 citations Open access
Semantic Scholar
Long Follow-up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma (RATHL) Trial (CRUK/07/033) Confirms the Safety of Both De-Escalation and Intensification of Chemotherapy
S. Luminari, A. Fosså, J. Trotman, D. Molin +8 more
2022Blood7 citations Open access
Semantic Scholar
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial
A. Fosså, Daniel Molin, P. Bröckelmann, G. Schneider +10 more
2025HemaSphere6 citations Open access
Semantic Scholar
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.
E. Zucca, L. Ceriani, G. Ciccone, A. Di Rocco +36 more
2025Blood6 citations
Semantic Scholar
Final analysis of the Phase III GHSG HD21 trial: PET-guided brecadd vs. ebeacopp in advanced-stage classical Hodgkin lymphoma
J. Ferdinandus, H. Kaul, A. Moccia, R. Greil +27 more
2025Blood6 citations
Semantic Scholar
Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.
M. Ozcan, S. T. Lee, F. Mensah, D. Modi +11 more
2023Journal of Clinical Oncology6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Borchmann×9
Invite
P. Borchmann — researcher profile on SciRah
D. Fajgenbaum×8
Invite
D. Fajgenbaum — researcher profile on SciRah
G. Schneider×8
Invite
G. Schneider — researcher profile on SciRah
V. Schaub×8
Invite
V. Schaub — researcher profile on SciRah

×8

Invite

F. Keil — researcher profile on SciRah

Invite

P. Kamper — researcher profile on SciRah

A. Huettmann×7

Invite

A. Huettmann — researcher profile on SciRah

Invite

Ø. Fluge — researcher profile on SciRah

Invite

M. Fuchs — researcher profile on SciRah

Invite

S. Pierson — researcher profile on SciRah

J. Ferdinandus×6

Invite

J. Ferdinandus — researcher profile on SciRah

Invite

A. Moccia — researcher profile on SciRah